New insights into immunomodulatory properties of lactic acid bacteria fermented herbal medicines

Hongru Zhu, Lidong Guo, Dan Yu, Xiaowei DuFrontiers in Microbiology 2022 · DOI

Introduction

The COVID-19 pandemic has intensified global interest in the human immune system. While traditional herbal medicines (THMs) are known for their immunomodulatory potential—offering multi-target effects with low toxicity—they often suffer from poor bioavailability. Many active compounds, such as complex polysaccharides and saponins, are too large or structurally intricate for efficient gut absorption.

Lactic acid bacteria (LAB) fermentation has emerged as a transformative strategy to overcome these hurdles. By utilizing "Generally Recognized as Safe" (GRAS) microbes as microscopic chemists, researchers can biotransform herbal substrates into more potent, bioavailable metabolites. This approach not only preserves the medicinal value but actively re-engineers it to enhance immune regulation through both innate and adaptive pathways.

The Synergistic Biotransformation

The relationship between LAB and herbal medicines is a bidirectional "handshake." Herbal ingredients often serve as prebiotics, promoting the growth of LAB and the production of beneficial metabolites like short-chain fatty acids (SCFAs), exopolysaccharides (EPS), and bacteriocins. Conversely, LAB enzymes (e.g., $\beta$-glucosidase) perform "deglycosylation," stripping sugar chains from large herbal molecules to create smaller, more active aglycones that are easier for the body to utilize.

Figure 1: Interaction between LAB and herbal medicines, highlighting the bidirectional flow of metabolites and their impact on the human immune barrier.

This biotransformation effectively optimizes natural products. For instance, fermentation can reduce the molecular weight of polysaccharides by up to 50%, facilitating better binding to immune cell receptors like TLR4 to trigger defense responses.

Mechanisms of Immunomodulation

Fermented herbal medicines regulate the immune response through several key mechanisms:

  1. Innate Immune Activation: Enhanced macrophage phagocytosis and natural killer (NK) cell cytotoxicity.
  2. Adaptive Immune Regulation: Balancing Th1/Th2 responses and increasing the production of antibodies such as IgA, IgG, and IgM.
  3. Gut Homeostasis: Upregulating tight junction proteins (e.g., occludin, ZO-1) to reinforce the intestinal barrier and prevent systemic inflammation.
  4. Metabolic Synergy: The production of SCFAs and EPS by LAB adds a secondary layer of immunomodulatory activity beyond the modified herbal compounds themselves.

Key Experimental Findings

Research across various models—from mouse macrophage cell lines (RAW 264.7) to human clinical trials—demonstrates significant quantitative improvements in potency following fermentation.

Table 1: Summary of the immunomodulatory effects and active ingredient changes in various fermented herbal medicines.

Notable highlights include:

  • Red Ginseng: Fermentation increased bioavailable ginsenosides (CK, Rh1, Rh2) by 67.5% and significantly raised serum IgA levels in human subjects compared to unfermented versions.
  • Astragalus: Fermented polysaccharides showed a 26.4% free radical scavenging rate, outperforming the 20.8% rate of unfermented versions.
  • Gynostemma: Fermentation led to a significant increase in the "immune organ index" and boosted antibody production in immunosuppressed models.

Future Directions

Despite promising results, several challenges remain. Future research should focus on elucidating complex chemical reactions like demethylation, optimizing strains by exploring "endophytic" LAB naturally found within medicinal plants, and tracking the survival of live LAB in the gut post-ingestion. Integrating metabolomics and transcriptomics will be essential to fully map the chemical-to-genetic pathways of these fermented products.

By bridging traditional wisdom with modern microbial biotechnology, LAB-mediated fermentation offers a powerful new frontier for natural immunotherapy.

Summary updated

Abstract

The COVID-19 pandemic has brought more attention to the immune system, the body's defense against infectious diseases. The immunomodulatory ability of traditional herbal medicine has been confirmed through clinical trial research, and has obvious advantages over prescription drugs due to its high number of potential targets and low toxicity. The active compounds of herbal drugs primarily include polysaccharides, saponins, flavonoids, and phenolics and can be modified to produce new active compounds after lactic acid bacteria (LAB) fermentation. LAB, primary source of probiotics, can produce additional immunomodulatory metabolites such as exopolysaccharides, short-chain fatty acids, and bacteriocins. Moreover, several compounds from herbal medicines can promote the growth and production of LAB-based immune active metabolites. Thus, LAB-mediated fermentation of herbal medicines has become a novel strategy for regulating human immune responses. The current review discusses the immunomodulatory properties and active compounds of LAB fermented herbal drugs, the interaction between LAB and herbal medicines, and changes in immunoregulatory components that occur during fermentation. This study also discusses the mechanisms by which LAB-fermented herbal medicines regulate the immune response, including activation of the innate or adaptive immune system and the maintenance of intestinal immune homeostasis.
BibTeX
@inproceedings{zhu2022new,
  author = {Hongru Zhu and Lidong Guo and Dan Yu and Xiaowei Du},
  title = {{New insights into immunomodulatory properties of lactic acid bacteria fermented herbal medicines}},
  booktitle = {Frontiers in Microbiology},
  year = {2022},
  doi = {10.3389/fmicb.2022.1073922},
}
Figure